Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney disease
Rupal Mehta, Monique E. Cho, Xuan Cai, Jungwha Lee, Jing Chen, Jiang He, John M. Flack, Tariq Shafi, Santosh L. Saraf, Valentin David, Harold I. Feldman, Tamara Isakova, Myles Wolf, Lawrence J. Appel, Alan S. Go, James P. Lash, Robert G. Nelson, Mahboob Rahman, Panduranga S. Rao, Vallabh O. Shah, Raymond R. Townsend, Mark L. Unruh
Topics & Concepts
MedicineKidney diseaseIron deficiencyTransferrin saturationHazard ratioInternal medicineHeart failureFerritinFibroblast growth factor 23HepcidinGastroenterologyAnemiaEndocrinologyConfidence intervalParathyroid hormoneCalciumParathyroid Disorders and TreatmentsHemoglobinopathies and Related DisordersIron Metabolism and Disorders